Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Return on Assets (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Return on Assets for 14 consecutive years, with 0.73% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 16.0% to 0.73% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.73% through Dec 2025, down 16.0% year-over-year, with the annual reading at 0.58% for FY2025, 7.0% down from the prior year.
  • Return on Assets hit 0.73% in Q4 2025 for Cardiff Oncology, down from 0.72% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.15% in Q1 2021 to a low of 0.73% in Q4 2025.
  • Historically, Return on Assets has averaged 0.43% across 5 years, with a median of 0.43% in 2023.
  • Biggest five-year swings in Return on Assets: soared 120bps in 2021 and later decreased -21bps in 2024.
  • Year by year, Return on Assets stood at 0.2% in 2021, then tumbled by -68bps to 0.33% in 2022, then tumbled by -49bps to 0.5% in 2023, then dropped by -14bps to 0.57% in 2024, then decreased by -29bps to 0.73% in 2025.
  • Business Quant data shows Return on Assets for CRDF at 0.73% in Q4 2025, 0.72% in Q3 2025, and 0.64% in Q2 2025.